Clinical Trials Directory

Trials / Completed

CompletedNCT04546763

Study Watch AF Detection At Home

Status
Completed
Phase
Study type
Observational
Enrollment
117 (actual)
Sponsor
Verily Life Sciences LLC · Industry
Sex
All
Age
22 Years
Healthy volunteers
Not accepted

Summary

This is a multi-center, prospective, non-randomized study to evaluate the performance of the study watch PPG algorithm in detecting irregular rhythms suggestive of atrial fibrillation (AF) in subjects at risk of having an event of AF in the free living (home) environment.

Conditions

Interventions

TypeNameDescription
DEVICEStudy WatchThe Study Watch is a miniaturized wearable device made with biocompatible contact materials containing various sensors capable of measuring physiological and environmental metrics.
DEVICEZio XTThe Zio XT Patch, the reference device, is a FDA-cleared single-patient use, continuously recording ECG monitor that can be worn up to 14 days.

Timeline

Start date
2020-09-03
Primary completion
2021-05-14
Completion
2021-05-14
First posted
2020-09-14
Last updated
2021-10-06

Locations

5 sites across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04546763. Inclusion in this directory is not an endorsement.